Journals / Turkish Journal of Pediatrics / 2015 / Cilt: 57 - Sayı: 3

Conventional and advanced MR imaging in infantile Refsum disease

Pages
294–299
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

A major contribution to the differential diagnosis came from MR imaging and proton MRS, as discussed in this report.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:We report magnetic resonance (MR) imaging findings including diffusionweighted imaging and proton MR spectroscopy findings in a patient with infantile Refsum disease.
📊
Key Findings & Data:Bilateral and symmetrical involvement of the peritrigonal white matter, centrum semiovale, thalami, corpus callosum and corticospinal tracts as assessed by increased T2 signal was highly suggestive of a peroxisomal disorder.
💡
Conclusion & Impact:A major contribution to the differential diagnosis came from MR imaging and proton MRS, as discussed in this report.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

We report magnetic resonance (MR) imaging findings including diffusionweighted imaging and proton MR spectroscopy findings in a patient with infantile Refsum disease. The initial diagnosis was made on the basis of history, clinical findings and biochemical studies. Bilateral and symmetrical involvement of the peritrigonal white matter, centrum semiovale, thalami, corpus callosum and corticospinal tracts as assessed by increased T2 signal was highly suggestive of a peroxisomal disorder. Facilitated diffusion was observed in diseased parenchyma. Long echo-time (TE: 270 ms) MRS showed decreased N-acetyl-aspartate/creatine and elevated choline/creatine and lactate; short echo-time MRS (TE: 30 ms) revealed increased myoinositol at 3.56 ppm and lipid peaks at 0.9 and 1.3 ppm. A major contribution to the differential diagnosis came from MR imaging and proton MRS, as discussed in this report.

🔖

Cite This Article

HALİLOĞLU, G., KARLI-OĞUZ, K., TOPÇU, M., WANDERS, R. J., KILIÇ, M., COŞKUN, T. (2022). Conventional and advanced MR imaging in infantile Refsum disease. Turkish Journal of Pediatrics, Cilt: 57 - Sayı: 3, 294–299. https://ajindex.com/articles/613278

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Steinberg SJ, Dodt G, Raymond GV, Braverman NE, Moser AB, Moser HW. Peroxisome biogenesis disorders. Biochim Biophys Acta 2006; 1763: 1733-1748
  2. Poll-The BT, Saudubray JM, Ogier H, et al. Infantile Refsum’s disease: biochemical findings suggesting multiple peroxisomal dysfunction. J Inherit Metab Dis 1986; 9: 169-174
  3. Lazarow PB, Moser HW. Disorders in peroxisome biogenesis. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds). The Metabolic and Molecular Basis of Inherited Disease (7th ed). New York: McGraw-Hill; 1995; 2287-2324
  4. Poll-The BT, Saudubray JM, Ogier HA, et al. Infantile Refsum disease: an inherited peroxisomal disorder. Comparison with Zellweger syndrome and neonatal adrenoleukodystrophy. Eur J Pediatr 1987; 146: 477- 483
  5. Wanders RJ, Schutgens RB, Schrakamp G, et al. Infantile Refsum disease: deficiency of catalase-containing particles (peroxisomes), alkyldihydroxyacetone phosphate synthase and peroxisomal beta-oxidation enzyme proteins. Eur J Pediatr 1986; 145: 172-175
  6. Paker AM, Sunness JS, Brereton NH, et al. Docosahexaenoic acid therapy in peroxisomal diseases: results of a double-blind, randomized trial. Neurology 2010; 75: 826-830. 7. van Maldergem L, Moser AB, Vincent MF, et al. Orthotopic liver transplantation from a living-related donor in an infant with a peroxisome biogenesis defect of the infantile Refsum disease type. J Inherit Metab Dis 2005; 28: 593-600
  7. Naidu S, Moser H. Infantile Refsum disease. AJNR Am J Neuroradiol 1991; 12: 1161-1163
  8. Bader PI, Dougherty S, Cangany N, Raymond G, Jackson CE. Infantile Refsum disease in four Amish sibs. Am J Med Genet 2000; 90: 110-114
  9. Ek J, Kase BF, Reith A, Björkhem I, Pedersen JI. Peroxisomal dysfunction in a boy with neurologic symptoms and amaurosis (Leber disease): clinical and biochemical findings similar to those observed in Zellweger syndrome. J Pediatr 1986; 108: 19-24
  10. Michelakakis HM, Zafeiriou DI, Moraitou MS, Gootjes J, Wanders RJ. PEX1 deficiency presenting as Leber congenital amaurosis. Pediatr Neurol 2004; 31: 146- 149
  11. Baumgartner M, Verhoeven N, Jacobs C, et al. Defective peroxisome biogenesis with a neuromuscular disorder resembling Werdnig-Hoffmann disease. Neurology 1998; 51: 1427-1432
  12. Moser AB, Rasmussen M, Naidu S, et al. Phenotype of patients with peroxisomal disorders subdivided into sixteen complementation groups. J Pediatr 1995; 127: 13-22
  13. Schiffmann R, van der Knaap MS. Invited article: an MRI-based approach to the dia